New guidelines recommend aspirin use in primary prevention for people ages 40 to 70 years old who are at higher risk of a first cardiovascular event, but not for those over 70.
Researchers provide a comprehensive review of the effects of movement-based mind-body interventions on chronic low back pain.
FAU Schmidt College of Medicine researchers examine benefits and risks of nonsteroidal anti-inflammatory drugs to provide guidance to health care providers and their patients in their clinical decision-making.
Researchers from FAU's Schmidt College of Medicine are the first to report on the neuroprotective properties of granulocyte colony-stimulating factor, an already FDA-approved drug.
Researchers examined racial and ethnic differences in genetic testing frequency and results among diverse breast cancer patients diagnosed at age 50 or younger from January 2007 to December 2017.
A review from researchers in FAU's Schmidt College of Medicine supports the use of high dose aspirin to treat acute migraine as well as low dose daily aspirin to prevent recurrent attacks.
The Schmidt College of Medicine program is one of only two in Florida's State University System to train future clinicians and scientists in this emerging field to understand and improve human health.
A novel study by FAU and the Oregon Research Institute is the first to show that regular use of prescription drugs for pain and sleep increases frailty risk in older adults by 95 percent.
FAU College of Engineering and Computer Science researchers developed algorithms that, combined with wearable sensors, can continuously monitor the severity of tremors in patients with Parkinson's disease.
FAU Schmidt College of Medicine researchers say that medical researchers must help the public understand the rigorous process of science to discern anecdotes and fake news from peer-reviewed scientific results.